ARHGEF2 and neoplasm: Microtubule destabilizing chemotherapy was shown to induce dendritic cell (DC) maturation—ultimately promoting anti-tumor T cell responses—via triggering the release of guanine nucleotide exchange factor-H1 (GEF-H1) in immature DCs and consequently activating Jun N-terminal kinase (JNK) (14).